[HTML][HTML] Течение и исходы COVID-19 у пациентов с иммуновоспалительными ревматическими заболеваниями: предварительные данные регистра НИИР …
ЕЛ Насонов, БС Белов, АМ Лила… - Научно …, 2021 - cyberleninka.ru
Представлены материалы Российской базы данных НИИР/АРР-С0УГО-19,
включавшей взрослых (старше 18 лет) пациентов с иммуновоспалительными …
включавшей взрослых (старше 18 лет) пациентов с иммуновоспалительными …
Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses
Abstract Outcomes of COrona VIrus Disease-19 (COVID-19) in patients with rheumatic
diseases (RDs) reported in various studies are heterogenous owing to the influence of age …
diseases (RDs) reported in various studies are heterogenous owing to the influence of age …
Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study
Background Although people living with cystic fibrosis (PwCF) often have some risk factors
for cardiovascular disease, including diabetes and chronic inflammation, little is known …
for cardiovascular disease, including diabetes and chronic inflammation, little is known …
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus
CC Mok, KL Chan, SM Tse - Vaccine, 2022 - Elsevier
Objectives To study the rate of SARS-CoV-2 vaccination and post-vaccination disease flares
in patients with systemic lupus erythematosus (SLE). Methods Patients who fulfilled≥ 4 of …
in patients with systemic lupus erythematosus (SLE). Methods Patients who fulfilled≥ 4 of …
[HTML][HTML] Вакцинация против SARS-CoV-2 при ревматических заболеваниях: вопросы безопасности
БС Белов, АМ Лила, ЕЛ Насонов - Научно-практическая …, 2022 - cyberleninka.ru
Проблема коронавирусной болезни 2019 (COVID-19, coronavirus disease 2019) спустя
два года по-прежнему остается актуальной как в социальном, так и в медицинском …
два года по-прежнему остается актуальной как в социальном, так и в медицинском …
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study
Objective To compare the risk of SARS-CoV-2 infection and its related severe sequelae
between patients with systemic lupus erythematosus (SLE) and the general population …
between patients with systemic lupus erythematosus (SLE) and the general population …
Systemic autoimmune diseases in patients hospitalized with COVID-19 in Spain: a nation-wide registry study
V Moreno-Torres, C de Mendoza, S Mellor-Pita… - Viruses, 2022 - mdpi.com
We aimed to evaluate the clinical outcome of Systemic Autoimmune Diseases (SADs)
patients hospitalized with COVID-19 in Spain, before the introduction of SARS-CoV-2 …
patients hospitalized with COVID-19 in Spain, before the introduction of SARS-CoV-2 …
Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in Japan
K Oku, Y Kimoto, T Horiuchi, M Yamamoto… - Modern …, 2023 - academic.oup.com
Objectives The incidence and prognosis of Coronavirus Disease 2019 (COVID-19) and
rheumatic disease vary among ethnicities and regions. COVID-19 outcomes in rheumatic …
rheumatic disease vary among ethnicities and regions. COVID-19 outcomes in rheumatic …
Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
Objectives We compared the outcomes of patients with or without systemic lupus
erythematosus (SLE) who were diagnosed with coronavirus disease 19 (COVID-19) and …
erythematosus (SLE) who were diagnosed with coronavirus disease 19 (COVID-19) and …
Autoimmune disease and COVID-19: a multicentre observational study in the United Kingdom
DJ Arachchillage, I Rajakaruna, C Pericleous… - …, 2022 - academic.oup.com
Objective To establish the demographic characteristics, laboratory findings and clinical
outcomes in patients with autoimmune disease (AD) compared with a propensity-matched …
outcomes in patients with autoimmune disease (AD) compared with a propensity-matched …